These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4434291)

  • 61. The significance of cerebral atrophy for the symptomatology of Parkinson's disease.
    Schneider E; Fischer PA; Jacobi P; Becker H; Hacker H
    J Neurol Sci; 1979 Jul; 42(2):187-97. PubMed ID: 479910
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cognitive and motor shifting aptitude disorder in Parkinson's disease.
    Cools AR; van den Bercken JH; Horstink MW; van Spaendonck KP; Berger HJ
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):443-53. PubMed ID: 6736974
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intellectual and cognitive functions in Parkinson's disease.
    Reitan RM; Boll TJ
    J Consult Clin Psychol; 1971 Dec; 37(3):364-9. PubMed ID: 5121817
    [No Abstract]   [Full Text] [Related]  

  • 64. Speed and power of higher cerebral functions in parkinsonian patients.
    Helscher RJ; Pinter MM
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):35-44. PubMed ID: 8439391
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of treatment with levodopa on Parkinson patients' social functioning and outlook on life.
    Singer E
    J Chronic Dis; 1974 Dec; 27(11-12):581-94. PubMed ID: 4436424
    [No Abstract]   [Full Text] [Related]  

  • 66. Sensorimotor control in Parkinsonism.
    Horne DJ
    J Neurol Neurosurg Psychiatry; 1973 Oct; 36(5):742-6. PubMed ID: 4753870
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neurotransmitters in the treatment of patients with severe head injuries.
    van Woerkom TC; Minderhoud JM; Gottschal T; Nicolai G
    Eur Neurol; 1982; 21(4):227-34. PubMed ID: 7117309
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Handwriting changes due to aging and Parkinson's syndrome.
    Walton J
    Forensic Sci Int; 1997 Aug; 88(3):197-214. PubMed ID: 9291592
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A LONGITUDINAL STUDY OF PSYCHOMOTOR FUNCTIONING IN ACUTE PSYCHIATRIC PATIENTS.
    COURT JH
    Br J Med Psychol; 1964; 37():167-73. PubMed ID: 14191885
    [No Abstract]   [Full Text] [Related]  

  • 70. THE EFFECT OF GENERAL ANXIETY AS AN INDEX OF LABILITY ON THE PERFORMANCE OF VARIOUS PSYCHOMOTOR TASKS.
    WASSENAAR GM
    J Gen Psychol; 1964 Oct; 71():351-7. PubMed ID: 14217923
    [No Abstract]   [Full Text] [Related]  

  • 71. FURTHER COMMENTS ON "PERFORMANCE ON A MOTOR TASK AS RELATED TO MAS SCORES".
    SPENCE JT
    Percept Mot Skills; 1963 Oct; 17():564. PubMed ID: 14057277
    [No Abstract]   [Full Text] [Related]  

  • 72. Ontogenetic and gerational components of structural and quantitative change in adult behavior.
    Nesselroade JR; Schaie KW; Baltes PB
    J Gerontol; 1972 Apr; 27(2):222-8. PubMed ID: 5060726
    [No Abstract]   [Full Text] [Related]  

  • 73. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Levodopa and cognitive disorders in Parkinson's disease].
    Leiva-Santana C; Alvarez-Saúco M
    Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of levodopa therapy in Parkinson's disease. II. Measurement of behavioural changes.
    Radbill R; Rosenberg G; Schwartz A
    Can Med Assoc J; 1974 Dec; 111(11):1218-22. PubMed ID: 4434291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease.
    Relja M; Klepac N
    J Neurol Sci; 2006 Oct; 248(1-2):251-4. PubMed ID: 16797593
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.